Enveric Biosciences, Inc. (ENVB)
USD 0.33
(-10.81%)
USD 0.33
(-10.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 39.91 Million | 42.99 Million |
| Cost of Revenue | 408.03 Thousand | 435.2 Thousand | 681.61 Thousand | 120.87 Thousand | 31.76 Million | 34.01 Million |
| Gross Profit | -408.03 Thousand | -435.2 Thousand | -681.61 Thousand | -120.87 Thousand | 8.15 Million | 8.98 Million |
| Operating Expenses | 16.44 Million | 19.96 Million | 25.94 Million | 5.61 Million | 14.47 Million | 13.69 Million |
| Selling, General and Administrative Expenses | 8.85 Million | 11.6 Million | 20.49 Million | 5.44 Million | 12.21 Million | 10.79 Million |
| Research and Development Expenses | 7.25 Million | 8.02 Million | 4.78 Million | 174.08 Thousand | - | - |
| Other Expenses | - | 327.91 Thousand | 656.64 Thousand | -802.1 Thousand | 2.26 Million | 88.16 Thousand |
| Cost and Expenses | 16.44 Million | 19.96 Million | 25.94 Million | 5.61 Million | 46.23 Million | 47.71 Million |
| Operating Income | -16.44 Million | -27.41 Million | -64.62 Million | -5.61 Million | -6.32 Million | -7.14 Million |
| Interest Expense | 3708.00 | 5249.00 | 10.31 Thousand | 445.25 Thousand | 691.13 Thousand | 729.89 Thousand |
| Income Tax Expense | 28.91 Thousand | -1.48 Million | -7.45 Million | -477.73 Thousand | 388.65 Thousand | 6.34 Million |
| Earnings before Tax | -17.26 Million | -19.95 Million | -56.43 Million | -6.86 Million | -5.21 Million | -10.54 Million |
| Net Income | -17.29 Thousand | -18.47 Million | -48.97 Million | -6.38 Million | -5.6 Million | -16.89 Million |
| Earnings Per Share Basic | -8.09 | -12.77 | -103.69 | -55.50 | -211.99 | -3551.39 |
| Earnings Per Share Diluted | -8.09 | -12.77 | -103.69 | -55.50 | -211.99 | -3551.39 |
| Weighted Average Shares Outstanding | 2.15 Million | 1.44 Million | 472.34 Thousand | 115.07 Thousand | 26.43 Thousand | 4758.00 |
| Weighted Average Shares Outstanding (Diluted) | 2.15 Million | 1.44 Million | 472.34 Thousand | 115.07 Thousand | 26.43 Thousand | 4758.00 |
| Gross Margin | - | - | - | - | 0.20 | 0.21 |
| EBIT Margin | - | - | - | - | -0.10 | -0.04 |
| Profit Margin | - | - | - | - | -0.14 | -0.39 |
| EBITDA | -17.13 Million | -19.63 Million | -63.96 Million | -6.29 Million | -2.32 Million | -6.91 Million |
| Earnings Before Tax Margin | - | - | - | - | -0.16 | -0.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 647.09 Thousand | - | - | - |
| Cost of Revenue | 84.77 Thousand | 85.4 Thousand | 84.68 Thousand | 408.03 Thousand | 95.83 Thousand | 114.37 Thousand |
| Gross Profit | -84.77 Thousand | -85.4 Thousand | 562.41 Thousand | -408.03 Thousand | -95.83 Thousand | -114.37 Thousand |
| Operating Expenses | 1.81 Million | 2.39 Million | 2.29 Million | 16.04 Million | 3.44 Million | 5.75 Million |
| Selling, General and Administrative Expenses | 1.29 Million | 1.93 Million | 930.68 Thousand | - | 2.01 Million | 3.15 Million |
| Research and Development Expenses | 515.5 Thousand | 458.15 Thousand | 1.36 Million | - | 1.35 Million | 2.51 Million |
| Other Expenses | 84.77 Thousand | 85.4 Thousand | 84.68 Thousand | 343.98 Thousand | 86.29 Thousand | 86.51 Thousand |
| Cost and Expenses | 1.89 Million | 2.47 Million | 2.38 Million | 16.44 Million | 3.44 Million | 5.75 Million |
| Operating Income | -1.89 Million | -2.47 Million | -2.38 Million | -16.44 Million | -3.44 Million | -5.75 Million |
| Interest Expense | -35.00 | 696.00 | 544.00 | 3708.00 | 2237.00 | 916.00 |
| Income Tax Expense | 1.00 | 1731.00 | 22.31 Thousand | 28.91 Thousand | -6595.00 | 607.75 Thousand |
| Earnings before Tax | -1.87 Million | -2.45 Million | -3.41 Million | -17.26 Million | -2.81 Million | -6.35 Million |
| Net Income | -1.87 Million | -2.45 Million | -3.43 Million | -17.31 Million | -2.82 Million | -6.36 Million |
| Earnings Per Share Basic | -0.25 | -0.61 | -1.46 | - | -1.30 | -3.02 |
| Earnings Per Share Diluted | -0.25 | -0.61 | -1.46 | - | -1.30 | -3.02 |
| Weighted Average Shares Outstanding | 7.58 Million | 4 Million | 2.34 Million | 2.15 Million | 2.16 Million | 2.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.58 Million | 4 Million | 2.34 Million | 2.15 Million | 2.16 Million | 2.1 Million |
| Gross Margin | - | - | 0.87 | - | - | - |
| EBIT Margin | - | - | -3.55 | - | - | - |
| Profit Margin | - | - | -5.31 | - | - | - |
| EBITDA | -1.81 Million | -2.39 Million | -2.29 Million | - | -2.74 Million | -5.03 Million |
| Earnings Before Tax Margin | - | - | -3.68 | - | - | - |
SLROF
AFFORDABLE
RAINBOWF
CPAU
DEEZR
SVRT